CA
CRBU icon

Cliff Asness’s Caribou Biosciences CRBU Stock Holding History

Cliff Asness’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,678
Closed -$29.8K – 3908
2026
Q1 		$29.8K Sell
15,678
-9,883
-39% -$17K ﹤0.01% 3726
2025
Q4 		$40.6K Sell
25,561
-35,846
-58% -$75.2K ﹤0.01% 3521
2025
Q3 		$143K Sell
61,407
-585,718
-91% -$1.11M ﹤0.01% 3321
2025
Q2 		$815K Buy
647,125
+121,247
+23% +$119K ﹤0.01% 2318
2025
Q1 		$480K Buy
525,878
+463,391
+742% +$602K ﹤0.01% 2446
2024
Q4 		$99.4K Sell
62,487
-51,238
-45% -$103K ﹤0.01% 2764
2024
Q3 		$223K Buy
113,725
+95,384
+520% +$195K ﹤0.01% 2520
2024
Q2 		$30.1K Buy
+18,341
New +$58.6K ﹤0.01% 2560

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cliff Asness's CRBU Position: Q2 2026 in Review

Cliff Asness sold out of Caribou Biosciences (CRBU) in Q2 2026, closing a stake of 15,678 shares — an estimated $29.8K sold.

Cliff Asness first reported a position in CRBU in Q2 2024 and held it in 8 quarters. The position peaked at $815K in Q2 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Cliff Asness reported no remaining Caribou Biosciences position as of Q2 2026 after selling out during the quarter.
  • Cliff Asness sold 15,678 Caribou Biosciences shares in Q2 2026, an estimated $29.8K.
  • Cliff Asness first reported a position in Caribou Biosciences in Q2 2024 and held it in 8 quarters.
  • Cliff Asness's Caribou Biosciences position peaked at $815K in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.